Tekla Life Sciences Investors Stock News

Double-digit dividends are rare. A sky-high yield of 27.2% is an outright income unicorn.

As an income investor, the 7.8% yield is quite attractive to me if HQL can support it. I continue my series on CEFs looking beyond the yield.

Healthcare offers essential services that people can't go without, recession or not. The Tekla funds can offer potential in any one of their funds for healthcare exposure.

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r

Just over one year after COVID-19 disrupted our lives, we are now getting to the point where multiple vaccine options are nearly ubiquitous for those in the United States. Per the CDC, as of April 12,

HQL has outperformed other healthcare-oriented CEFs over the past year. It's selling at a -7.27% discount to NAV.

BOSTON--(BUSINESS WIRE)--On December 21, 2020, Tekla Life Sciences Investors declared a special cash distribution of $0.02 per share in order to satisfy annual tax distribution requirements. The recor

We analyze performance trends in closed-end-funds this year along with themes by asset classes. Equity funds with concentrated exposure to Technology and Healthcare are among the biggest winners this

On October 9, 2020, Tekla World Healthcare Fund declared its monthly cash distribution of $0.1167 per share. The record date for the monthly cash dist

On September 30, 2020, Tekla World Healthcare Fund paid a monthly distribution of $0.1167 per share. It is currently estimated that this distribution

Barron's Weekly lists stocks announcing dividend payment boosts on the very last page of its financial data.

On August 17, 2020, Tekla Life Sciences Investors declared a stock distribution of $0.41 per share. The record date for the stock distribution is August 28, 2020 and the payable date is September 30,

Oxford Square Capital (NASDAQ:OXSQ) and Tekla Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better stock? We will compare the two businesses based on the st